bladder cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (i) histologically confirmed urothelial cancer (ii) T2-T4N0M0 with or without hydronephrosis (iii) WHOperformance status 0-2 (iv) clinically inoperable or refused surgery (v) provision of written informed consent.
Exclusion criteria
Exclusion criteria: Patients with tumors that covered all or most of the bladder wall and patients with small cell carcinoma were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| treatment related toxicity local control rate | — |
Countries
Japan
Contacts
Hokkaido University Graduate School of Medicine Department of Radiation Oncology